Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evolving perspectives in contralateral breast cancer.

L A Dawson1, E Chow, P E Goss

  • 1Department of Radiation Oncology, University of Toronto, Canada.

European Journal of Cancer (Oxford, England : 1990)
|March 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of stereotactic body radiotherapy in the management of hepatocellular carcinoma with macroscopic vascular invasion: a narrative review.

ESMO gastrointestinal oncology·2026
Same author

Tumour-Specific Growth Rate as a Potential Predictor of Outcomes in Oligoprogressive Disease Treated With Stereotactic Body Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

The maximum dose of atorvastatin and simvastatin as well as rosuvastatin should be restricted in East Asians.

Hong Kong medical journal = Xianggang yi xue za zhi·2024
Same author

Morphological and topological responses of roots to defoliation and nitrogen supply in Lolium perenne and Festuca ovina.

The New phytologist·2021
Same author

A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant Therapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2021
Same journal

Early-onset colorectal cancer across Europe: Burden, mechanisms, and health-system implications.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinical urgency of incidental findings in the first year of the 4-IN-THE-LUNG-RUN lung cancer screening program.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Mapping the anatomical landscape of colorectal tumours: Location-specific efficacy of anti-epidermal growth factor receptor antibodies: Pooled analysis of randomised trials.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Left behind but not left alone: Excluded cell populations in the non-small cell lung cancer stroma predict superior long-term overall survival.

European journal of cancer (Oxford, England : 1990)·2026
Same journal

Survival outcomes of adjuvant therapy in resected stage III melanoma: Results from a real-life cohort study (TAMARIS).

European journal of cancer (Oxford, England : 1990)·2026
See all related articles

Contralateral breast cancer (CBC) management remains controversial. While tamoxifen and ovarian ablation show promise in prevention, early detection via mammography lacks proven survival benefits, necessitating further research.

Area of Science:

  • Oncology
  • Breast Cancer Research
  • Clinical Management

Background:

  • Contralateral breast cancer (CBC) incidence, risk factors, and optimal management are debated.
  • Existing literature lacks definitive guidelines for screening and prevention of secondary breast tumors.
  • Understanding risk factors is crucial for personalized surveillance and treatment strategies.

Purpose of the Study:

  • To review the incidence, predisposing factors, prevention, and treatment of bilateral breast cancer.
  • To synthesize current evidence on screening and preventative measures for contralateral tumors.
  • To define optimal clinical management strategies for contralateral breast cancer.

Main Methods:

  • Comprehensive literature review of publications on contralateral breast cancer.

Related Experiment Videos

  • Analysis of identified risk factors, including age, genetics, radiation, and tumor histology.
  • Evaluation of evidence for surveillance, preventative therapies, and surgical interventions.

    • Main Results:

    • Identified risk factors for CBC include young age, germline mutations, family history, radiation, lobular carcinoma in situ (LCIS), invasive lobular carcinoma, and multicentricity.
    • Contralateral mammographic surveillance aids early detection but lacks demonstrated survival benefit.
    • Adjuvant tamoxifen, ovarian ablation, and prednisone show potential in reducing CBC incidence.

    Conclusions:

    • Contralateral breast surveillance should include breast self-examination, physical exams, and annual mammography.
    • Contralateral prophylactic mastectomy and biopsies do not reduce mortality in primary breast cancer patients.
    • CBC should be treated similarly to primary breast cancer if no distant metastasis is present, considering prior therapies.